Serum Tissue Inhibitor of Matrix Metalloproteinase-1 Levels Are Associated With Mortality in Patients With Malignant Middle Cerebral Artery Infarction

BMC Neurology - United Kingdom
doi 10.1186/s12883-015-0364-7